12 Most Undervalued Stocks to Invest In

10. The Cigna Group (NYSE:CI)

On May 20, 2026, Morgan Stanley raised the firm’s price target on The Cigna Group (NYSE:CI) to $361 from $355 and maintained an Overweight rating on the shares. Morgan Stanley said meetings with management “reinforced the underappreciated” specialty opportunity. The firm added that the September investor day should give Cigna a platform to emphasize its increasingly Specialty-centric long-term focus.

UBS also raised the firm’s price target on The Cigna Group (NYSE:CI) to $400 from $375 and maintained a Buy rating on the shares. UBS said managed care organizations broadly raised guidance after stronger-than-expected Q1 results, supported by favorable respiratory trends and seasonal cost patterns. The firm also cited improved Medicare Advantage rates, steadier ACA exchange enrollment, and modest Medicaid outperformance, while noting ongoing cost pressures from specialty drugs, GLP-1s, and behavioral health.

Last month, The Cigna Group (NYSE:CI) reported Q1 adjusted EPS of $7.79, ahead of the consensus estimate of $7.61. Revenue totaled $68.49B, above the consensus estimate of $66.2B. Chairman and CEO David M. Cordani said the quarter was driven by “disciplined execution,” portfolio shaping, and targeted innovation.

The Cigna Group (NYSE:CI) provides insurance and related products and services in the United States.